Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Kanbayashi

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Clinical Drug Investigation|January 20, 2017
Predictors of the Usefulness of Corticosteroids for Cancer-Related Fatigue in End-of-Life PatientsYuko Kanbayashi, Toyoshi Hosokawa
Journal of Palliative Medicine|April 8, 2014
Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?Yuko Kanbayashi, Toyoshi Hosokawa
Current Pain and Headache Reports|September 3, 2013
Vaccination against and treatment of acute herpes zoster for prevention of post-herpetic neuralgiaYuko Kanbayashi, Toyoshi Hosokawa
Hepato-Gastroenterology|February 24, 2016
Predictive Factors for NSAIDs-related Gastrointestinal Toxicity: Can COX-2 Selective Inhibtor Prevent it?Yuko Kanbayashi, Hideyuki Konishi
Clinical Drug Investigation|October 8, 2025
Disproportionality Analysis of Pulmonary Adverse Events Associated with Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report DatabaseYuko Kanbayashi, Risa Morioka, Keiko Hosohata
The Clinical Journal of Pain|June 19, 2013
Commentary on "letter to the editor for article titled predictive factors for postherpetic neuralgia using ordered logistic regression analysis"Yuko Kanbayashi, Keiko Ohnishi, Toyoshi Hosokawa
Pain Research & Management|June 20, 2014
Factors predicting adverse events associated with pregabalin administered for neuropathic pain reliefYuko Kanbayashi, Keiko Onishi, Toyoshi Hosokawa
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 24, 2026
Cardiac adverse events associated with axitinib: A real-world pharmacovigilance study based on the Japanese adverse drug event report databaseKeiko Hosohata, Risa Morioka, Riku Nakamoto, et al.
In Vivo (Athens, Greece)|October 30, 2025
Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report databaseYuko Kanbayashi, Risa Morioka, Koichi Takayama, et al.
Oncology|January 10, 2024
Predictors for the Development of Thromboembolic Events in Cancer Patients Treated with Bevacizumab, Ramucirumab, and Aflibercept: A Single-Institution Retrospective AnalysisYuko Kanbayashi, Takeshi Ishikawa, Eigo Otsuji, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Clinical Drug Investigation|January 20, 2017
Predictors of the Usefulness of Corticosteroids for Cancer-Related Fatigue in End-of-Life PatientsYuko Kanbayashi, Toyoshi Hosokawa
Journal of Palliative Medicine|April 8, 2014
Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?Yuko Kanbayashi, Toyoshi Hosokawa
Current Pain and Headache Reports|September 3, 2013
Vaccination against and treatment of acute herpes zoster for prevention of post-herpetic neuralgiaYuko Kanbayashi, Toyoshi Hosokawa
Hepato-Gastroenterology|February 24, 2016
Predictive Factors for NSAIDs-related Gastrointestinal Toxicity: Can COX-2 Selective Inhibtor Prevent it?Yuko Kanbayashi, Hideyuki Konishi
Clinical Drug Investigation|October 8, 2025
Disproportionality Analysis of Pulmonary Adverse Events Associated with Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report DatabaseYuko Kanbayashi, Risa Morioka, Keiko Hosohata
The Clinical Journal of Pain|June 19, 2013
Commentary on "letter to the editor for article titled predictive factors for postherpetic neuralgia using ordered logistic regression analysis"Yuko Kanbayashi, Keiko Ohnishi, Toyoshi Hosokawa
Pain Research & Management|June 20, 2014
Factors predicting adverse events associated with pregabalin administered for neuropathic pain reliefYuko Kanbayashi, Keiko Onishi, Toyoshi Hosokawa
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 24, 2026
Cardiac adverse events associated with axitinib: A real-world pharmacovigilance study based on the Japanese adverse drug event report databaseKeiko Hosohata, Risa Morioka, Riku Nakamoto, et al.
In Vivo (Athens, Greece)|October 30, 2025
Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report databaseYuko Kanbayashi, Risa Morioka, Koichi Takayama, et al.
Oncology|January 10, 2024
Predictors for the Development of Thromboembolic Events in Cancer Patients Treated with Bevacizumab, Ramucirumab, and Aflibercept: A Single-Institution Retrospective AnalysisYuko Kanbayashi, Takeshi Ishikawa, Eigo Otsuji, et al.
Pageof 6